Healthcare Sector

Members of Parliament invested in the Healthcare Sector

156 investments

71 companies

Investors

Filed	Name	Company	Pur. £	Cur. £	P/L %	MPV*
Feb '17	Lord Arbuthnot of Edrom	Neuro-bio / NMS:NBIX	£43.24	£134.66	211.42%	£217,997.22
Apr '16	Baroness Greenfield	Neuro-bio / NMS:NBIX	£46.13	£134.66	191.91%	£204,339.91
Apr '24	Lord Balfe	Astrazeneca / LSE:AZN.L	£12,024.00	£13,508.00	12.34%	£78,639.39
Dec '16	Lord Burns	Astrazeneca / LSE:AZN.L	£4,116.00	£13,508.00	228.18%	£229,727.89
May '20	Lord Deighton	Astrazeneca / LSE:AZN.L	£8,361.00	£11,236.00	34.39%	£94,070.09**
Mar '14	Viscount Eccles	Astrazeneca / LSE:AZN.L	£3,876.50	£13,508.00	248.46%	£243,921.06
Feb '21	Lord Etherton	Astrazeneca / LSE:AZN.L	£7,422.00	£13,508.00	82.00%	£127,399.62
May '23	Lord Fink	Astrazeneca / LSE:AZN.L	£11,774.00	£13,508.00	14.73%	£80,309.16
Sep '16	Lord Gadhia	Astrazeneca / LSE:AZN.L	£5,099.00	£10,024.00	96.59%	£137,611.30**
Apr '12	Lord Glendonbrook	Astrazeneca / LSE:AZN.L	£2,666.50	£13,508.00	406.58%	£354,607.16
May '24	Lord Goldsmith	Astrazeneca / LSE:AZN.L	£12,156.00	£13,508.00	11.12%	£77,785.46
May '18	Lord Grabiner	Astrazeneca / LSE:AZN.L	£5,417.00	£13,508.00	149.36%	£174,554.18
May '23	Lord Leitch	Astrazeneca / LSE:AZN.L	£11,820.00	£12,340.00	4.40%	£73,079.53**
May '23	Lord Londesborough	Astrazeneca / LSE:AZN.L	£11,924.00	£13,880.00	16.40%	£81,482.72
Nov '23	Lord Mance	Astrazeneca / LSE:AZN.L	£10,230.00	£13,880.00	35.68%	£94,975.56
Jun '21	Lord Morse	Astrazeneca / LSE:AZN.L	£8,005.00	£13,880.00	73.39%	£121,374.14
Apr '10	Baroness Noakes	Astrazeneca / LSE:AZN.L	£2,938.00	£13,880.00	372.43%	£330,701.16
Dec '23	Lord Browne of Madingley	Allurion / NYQ:ALUR	£3.31	£1.48	-55.29%	£31,299.09
Dec '16	Lord Burns	Glaxosmithkline / NYQ:GSK	£37.39	£50.10	33.99%	£93,795.13
Mar '14	Baroness Eccles of Moulton	Glaxosmithkline / NYQ:GSK	£53.43	£50.10	-6.23%	£65,637.28
Apr '21	Lord Farmer	Glaxosmithkline / NYQ:GSK	£36.65	£40.88	11.54%	£78,079.12**
Jan '20	Lord Gadhia	Glaxosmithkline / NYQ:GSK	£46.50	£40.95	-11.94%	£61,645.16**
May '11	Lord Glendonbrook	Glaxosmithkline / NYQ:GSK	£42.78	£50.10	17.11%	£81,977.56
Apr '10	Lord Levene of Portsoken	Glaxosmithkline / NYQ:GSK	£39.38	£50.80	29.00%	£90,299.64
Mar '17	Lord Lloyd-Webber	Glaxosmithkline / NYQ:GSK	£42.31	£50.80	20.07%	£84,046.32
Apr '10	Baroness Noakes	Glaxosmithkline / NYQ:GSK	£39.49	£50.80	28.64%	£90,048.11
Jan '13	Lord Sassoon	Glaxosmithkline / NYQ:GSK	£44.75	£50.80	13.52%	£79,463.69
Oct '20	Lord Taverne	Glaxosmithkline / NYQ:GSK	£37.57	£40.95	9.00%	£76,297.58**
May '24	Lord Balfe	Glaxosmithkline / NYQ:GSK	£44.02	£50.10	13.81%	£79,668.33
May '25	Lord Hayward	Glaxosmithkline / NYQ:GSK	£37.37	£50.10	34.06%	£93,845.33
Aug '14	Lord Carter of Coles	Johnson & Johnson / NYQ:JNJ	£100.16	£161.55	61.29%	£112,904.35**
Apr '22	Lord Cromwell	Johnson & Johnson / NYQ:JNJ	£179.90	£154.37	-14.19%	£60,066.15**
May '23	Lord Fink	Johnson & Johnson / NYQ:JNJ	£165.03	£227.72	37.99%	£96,590.92
Jul '16	Lord Lloyd-Webber	Johnson & Johnson / NYQ:JNJ	£122.64	£224.44	83.01%	£128,105.03
Jan '13	Lord Sassoon	Johnson & Johnson / NYQ:JNJ	£72.69	£224.44	208.76%	£216,134.27
Aug '17	Lord Sterling of Plaistow	Johnson & Johnson / NYQ:JNJ	£133.45	£157.98	18.38%	£82,866.99**
Feb '11	Lord Wasserman	Johnson & Johnson / NYQ:JNJ	£60.93	£224.44	268.36%	£257,849.99
Mar '25	Lord Fink	Johnson & Johnson / NYQ:JNJ	£161.72	£227.72	40.81%	£98,567.89
Aug '18	Lord Carter of Coles	Danaher / NYQ:DHR	£90.94	£223.01	145.23%	£171,659.87**
Apr '22	Lord Cromwell	Danaher / NYQ:DHR	£245.55	£201.40	-17.98%	£57,414.25**
Jul '16	Lord Glendonbrook	Danaher / NYQ:DHR	£72.15	£224.54	211.19%	£217,836.06
Apr '22	Lord Grabiner	Danaher / NYQ:DHR	£248.88	£224.54	-9.78%	£63,153.37
Aug '17	Lord Sterling of Plaistow	Danaher / NYQ:DHR	£71.88	£212.78	196.02%	£207,216.44**
Jul '18	Lord Carter of Coles	Essilor International / VIE:EI.VI	£126.10	£316.70	151.15%	£175,804.93**
Aug '18	Lord Carter of Coles	Unitedhealth Group / NYQ:UNH	£253.22	£294.02	16.11%	£81,278.73
Jan '23	Lord Goldsmith	Unitedhealth Group / NYQ:UNH	£490.06	£294.02	-40.00%	£41,997.71
Nov '23	Lord Mance	Unitedhealth Group / NYQ:UNH	£537.83	£282.70	-47.44%	£36,794.15
Jan '18	Lord Sterling of Plaistow	Unitedhealth Group / NYQ:UNH	£221.16	£380.64	72.11%	£120,477.48**
Mar '25	Lord Fink	Unitedhealth Group / NYQ:UNH	£518.20	£294.02	-43.26%	£39,717.10
Apr '25	Lord Grabiner	Unitedhealth Group / NYQ:UNH	£594.40	£294.02	-50.53%	£34,625.50
Oct '25	Lord Sterling of Plaistow	Unitedhealth Group / NYQ:UNH	£361.15	£356.26	-1.35%	£69,052.20**
Feb '19	Lord Carter of Coles	Mettler Toledo / NYQ:MTD	£672.49	£1,401.64	108.43%	£145,897.79
May '19	Lord Sterling of Plaistow	Mettler Toledo / NYQ:MTD	£701.77	£1,481.07	111.05%	£147,733.44**
Sep '20	Lord Carter of Coles	Thermo Fisher Scientific / NYQ:TMO	£418.14	£608.02	45.41%	£101,787.44
Apr '22	Lord Grabiner	Thermo Fisher Scientific / NYQ:TMO	£570.94	£438.15	-23.26%	£53,719.30**
May '18	Lord Green of Hurstpierpoint	Thermo Fisher Scientific / NYQ:TMO	£215.97	£423.55	96.12%	£137,280.64**
Nov '23	Lord Mance	Thermo Fisher Scientific / NYQ:TMO	£459.24	£623.91	35.86%	£95,099.95
Aug '20	Lord Sterling of Plaistow	Thermo Fisher Scientific / NYQ:TMO	£416.17	£403.13	-3.13%	£67,806.66**
Jan '25	Lord Sassoon	Thermo Fisher Scientific / NYQ:TMO	£583.64	£623.91	6.90%	£74,829.86
Aug '25	Lord Green of Hurstpierpoint	Thermo Fisher Scientific / NYQ:TMO	£463.04	£608.02	31.31%	£91,917.33
Aug '25	Lord Sterling of Plaistow	Thermo Fisher Scientific / NYQ:TMO	£477.41	£623.91	30.69%	£91,480.48
Sep '21	Lord Darzi of Denham	Oxford Nanopore / LSE:ONT.L	£612.60	£162.80	-73.42%	£18,602.68
Apr '22	Lord Spencer of Alresford	Oxford Nanopore / LSE:ONT.L	£320.00	£171.20	-46.50%	£37,450.00
Apr '21	Baroness Deech	Novo Nordisk As / NYQ:NVO	£36.35	£60.33	65.97%	£116,178.83
Apr '24	Lord Grabiner	Novo Nordisk As / NYQ:NVO	£127.46	£64.73	-49.22%	£35,549.19**
Nov '23	Lord Mance	Novo Nordisk As / NYQ:NVO	£101.69	£62.89	-38.16%	£43,291.37
May '22	Lord Reay	Novo Nordisk As / NYQ:NVO	£56.40	£140.80	149.67%	£174,767.27**
Nov '21	Lord Sherbourne of Didsbury	Novo Nordisk As / NYQ:NVO	£56.71	£70.73	24.73%	£87,313.29**
Apr '24	Lord Willoughby de Broke	Novo Nordisk As / NYQ:NVO	£122.75	£62.89	-48.77%	£35,863.95
May '24	Lord Londesborough	Novo Nordisk As / NYQ:NVO	£134.66	£62.89	-53.30%	£32,691.96
Apr '21	Baroness Deech	Zoetis / NYQ:ZTS	£168.10	£121.93	-27.47%	£50,773.94
Mar '25	Lord Fink	Zoetis / NYQ:ZTS	£162.82	£121.93	-25.11%	£52,420.46
Apr '21	Baroness Deech	Novartis / NYQ:NVS	£88.38	£147.87	67.31%	£117,118.13
Apr '17	Lord Donoughue	Novartis / NYQ:NVS	£66.05	£147.87	123.88%	£156,716.92
May '11	Lord Glendonbrook	Novartis / NYQ:NVS	£54.04	£147.87	173.62%	£191,537.13
Apr '23	Lord Grabiner	Novartis / NYQ:NVS	£95.80	£107.52	12.23%	£78,563.67**
Oct '19	Lord Farmer	Centene / NYQ:CNC	£44.09	£72.71	64.91%	£115,438.87**
May '23	Lord Fink	Healthcare Group / LSE:SPI.L	£227.50	£210.00	-7.69%	£64,615.38
Jan '24	Lord Fink	Roche / EBS:ROG.SW	£251.85	£338.30	34.33%	£94,028.19
Apr '21	Lord Grabiner	Roche / EBS:ROG.SW	£309.65	£338.30	9.25%	£76,476.67
Apr '17	Lord Leigh of Hurley	Roche / EBS:ROG.SW	£255.80	£338.30	32.25%	£92,576.23
Aug '20	Lord Reay	Roche / EBS:ROG.SW	£315.05	£249.80	-20.71%	£55,502.30**
Feb '25	Lord Green of Hurstpierpoint	Roche / EBS:ROG.SW	£285.70	£272.40	-4.66%	£66,741.33**
Mar '25	Lord Fink	Roche / EBS:ROG.SW	£303.00	£338.30	11.65%	£78,155.11
Nov '25	Lord Green of Hurstpierpoint	Roche / EBS:ROG.SW	£309.00	£338.30	9.48%	£76,637.54
May '11	Lord Glendonbrook	Abbott Laboratories / NYQ:ABT	£25.27	£106.05	319.73%	£293,810.71
May '23	Lord Londesborough	Abbott Laboratories / NYQ:ABT	£108.82	£108.27	-0.51%	£69,646.20
Jan '13	Lord Sassoon	Abbott Laboratories / NYQ:ABT	£32.90	£108.27	229.09%	£230,361.68
May '11	Lord Glendonbrook	Mesoblast / NMS:MESO	£101.20	£18.70	-81.52%	£12,934.78
May '11	Lord Glendonbrook	Pfizer / NYQ:PFE	£19.54	£25.86	32.31%	£92,618.97
Feb '16	Lord Lloyd-Webber	Pfizer / NYQ:PFE	£29.02	£26.50	-8.69%	£63,915.33
May '11	Lord Glendonbrook	Smith & Nephew / NYQ:SNN	£22.61	£33.86	49.79%	£104,852.72
Apr '10	Baroness Noakes	Smith & Nephew / NYQ:SNN	£20.98	£34.08	62.44%	£113,706.18
Jan '13	Lord Glendonbrook	Waters / NYQ:WAT	£87.09	£385.03	342.11%	£309,474.12
Oct '13	Lord Glendonbrook	Stryker / NYQ:SYK	£69.42	£357.83	415.46%	£360,819.65
Nov '23	Lord Mance	Stryker / NYQ:SYK	£275.00	£354.57	28.93%	£90,254.18
Mar '14	Lord Glendonbrook	Bb Biotech / EBS:BION.SW	£33.36	£27.20	-18.47%	£57,074.34**
Jun '16	Lord Lloyd-Webber	Bb Biotech / EBS:BION.SW	£47.80	£48.05	0.52%	£70,366.11
Mar '17	Lord Lloyd-Webber	Bb Biotech / EBS:BION.SW	£54.95	£48.05	-12.56%	£61,210.19
Oct '20	Lord Glendonbrook	Bds / NGM:BDSX	£12.81	£10.33	-19.36%	£56,448.09
May '15	Lord Glendonbrook	Medtronic / NYQ:MDT	£78.41	£86.77	10.66%	£77,463.33**
Dec '25	Lord Sassoon	Medtronic / NYQ:MDT	£100.77	£100.69	-0.08%	£69,944.43
Jan '18	Lord Glendonbrook	Cvs Health / NYQ:CVS	£79.44	£74.03	-6.81%	£65,232.88
Feb '13	Lord Nash	Cvs Health / NYQ:CVS	£52.66	£77.90	47.93%	£103,551.08**
Jul '18	Lord Glendonbrook	Bayer / GER:BAYN.DE	£95.26	£45.19	-52.56%	£33,207.01
Jun '19	Lord Glendonbrook	Alcon / NYQ:ALC	£59.11	£80.92	36.90%	£95,828.11**
Dec '19	Lord Glendonbrook	Align Technology / NMS:ALGN	£273.75	£164.92	-39.76%	£42,171.32
May '24	Lord Goldsmith	Abbvie / NYQ:ABBV	£160.81	£218.67	35.98%	£95,186.25
Apr '21	Lord Grabiner	Boston Scientific / NYQ:BSX	£39.32	£93.67	138.22%	£166,757.37**
Apr '22	Lord Grabiner	Intuitive Surgical / NMS:ISRG	£277.85	£522.04	87.89%	£131,519.88
Jan '22	Lord Green of Hurstpierpoint	Intuitive Surgical / NMS:ISRG	£284.18	£529.42	86.30%	£130,408.19**
Nov '21	Lord Sherbourne of Didsbury	Intuitive Surgical / NMS:ISRG	£350.79	£525.04	49.67%	£104,771.51
Oct '25	Lord Carter of Coles	Intuitive Surgical / NMS:ISRG	£551.30	£522.04	-5.31%	£66,284.78
Oct '15	Lord Hayward	Sage / NGM:SAGE	£46.11	£8.68	-81.18%	£13,177.19
Dec '22	Lord Hintze	Atai Life Sciences / NGM:ATAI	£3.48	£3.87	11.21%	£77,844.83
Dec '22	Lord Hintze	Affimed / NGM:AFMD	£21.20	£0.18	-99.14%	£599.29
Mar '11	Lord Hollick	HCA / NYQ:HCA	£31.02	£491.23	1,483.59%	£1,108,513.89
Nov '17	Lord Howard of Rising	Ekf Diagnostics / LSE:EKF.L	£25.01	£25.60	2.36%	£71,650.76
Apr '22	Lord Hylton	Genus / LSE:GNS.L	£2,678.00	£3,035.00	13.33%	£79,331.59
Jan '24	Lord Kakkar	Cyte / NMS:CTKB	£8.31	£3.71	-55.35%	£31,251.50**
Apr '10	Lord Lloyd-Webber	Idexx Labs / NMS:IDXX	£29.96	£694.75	2,218.93%	£1,623,247.72
Aug '16	Lord Lloyd-Webber	Eli Lilly / NYQ:LLY	£80.55	£67.15	-16.64%	£58,355.06**
Apr '24	Lord Mendoza	Eli Lilly / NYQ:LLY	£731.33	£1,039.51	42.14%	£99,497.76
Mar '17	Lord Lloyd-Webber	Hikma Pharmaceuticals / LSE:HIK.L	£2,026.00	£1,545.00	-23.74%	£53,381.05
Sep '21	Lord Londesborough	Definitive Healthcare / NMS:DH	£43.29	£2.39	-94.48%	£3,864.63
Jul '21	Lord Londesborough	Goodrx / NMS:GDRX	£32.52	£4.79	-85.27%	£10,310.58**
Nov '23	Lord Mance	Eli Lilly Co / VIE:LLYC.VI	£557.00	£888.10	59.44%	£111,610.41
Mar '24	Lord Moynihan of Chelsea	Candel Therapeutics / NGM:CADL	£1.40	£6.10	335.71%	£305,000.00
Mar '24	Lord Moynihan of Chelsea	Journey Medical / NCM:DERM	£3.74	£7.25	93.85%	£135,695.19**
Mar '24	Lord Moynihan of Chelsea	Evotec / NMS:EVO	£7.13	£3.66	-48.67%	£35,932.68
Mar '24	Lord Moynihan of Chelsea	Fortress Biotech / NCM:FBIO	£1.92	£3.46	80.21%	£126,145.83
Mar '24	Lord Moynihan of Chelsea	Mustang Bio / NCM:MBIO	£1.04	£1.02	-1.92%	£68,653.84
Mar '24	Lord Moynihan of Chelsea	Tg Therapeutics / NCM:TGTX	£15.05	£30.80	104.65%	£143,255.81
Mar '24	Lord Moynihan of Chelsea	Adaptimmune / NMS:ADAP	£1.47	£0.03	-98.28%	£1,207.14
Mar '24	Lord Moynihan of Chelsea	Avenue Therapeutics / NCM:ATXI	£12.00	£0.29	-97.56%	£1,706.25
Apr '19	Lord Nash	Eq / NCM:EQ	£8.20	£0.69	-91.59%	£5,890.24**
Aug '23	Lord Nash	Relay / NGM:RLAY	£10.62	£8.50	-19.96%	£56,026.37
Sep '23	Lord Nash	Abingdon / LSE:ABDX.L	£11.25	£6.00	-46.67%	£37,333.33
Mar '24	Lord Petitgas	Royalty Pharma / NMS:RPRX	£30.08	£40.74	35.44%	£94,807.18
Mar '24	Lord Petitgas	Moderna / NMS:MRNA	£111.98	£45.45	-59.41%	£28,411.32
May '23	Lord Reay	Sanofi / NMS:SNY	£55.11	£47.22	-14.32%	£59,978.23**
May '22	Lord Saatchi	Walgreen / NMS:WBA	£43.85	£11.98	-72.68%	£19,124.29
Jul '23	Lord Sassoon	Haleon / LSE:HLN.L	£336.10	£376.60	12.05%	£78,434.99
Mar '23	Baroness Shields	Benevolentai / AMS:BAI.AS	£2.46	£0.09	-96.14%	£2,703.25**
Jan '21	Lord Spencer of Alresford	Immupharma / LSE:IMM.L	£12.65	£6.96	-44.98%	£38,513.83
May '23	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£180.80	£204.10	12.89%	£79,023.12**
Jun '24	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£208.20	£197.20	-5.28%	£66,301.63**
Aug '24	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£207.50	£257.00	23.86%	£86,698.80
Mar '25	Lord Fink	Essilorluxottica / PAR:EL.PA	£273.20	£253.30	-7.28%	£64,901.17
Jun '22	Lord Stevens of Ludgate	Verici Dx / LSE:VRCI.L	£26.00	£0.73	-97.21%	£1,951.92
May '23	Lord Stevens of Ludgate	Avacta Group / LSE:AVCT.L	£112.00	£53.00	-52.68%	£33,125.00
Jul '25	Lord Fink	Avacta Group / LSE:AVCT.L	£51.50	£54.00	4.85%	£73,398.06
Jun '22	Lord Sugar	Acl / NMS:ACLX	£17.47	£68.51	292.16%	£274,510.61
May '22	Lord Triesman	Blue / NMS:BLUE	£3.39	£4.97	46.61%	£102,625.36
May '20	Lord Wolfson of Aspley Guise	Adc Therapeutics / NYQ:ADCT	£30.00	£3.59	-88.03%	£8,376.67
Nov '24	Lord Moynihan of Chelsea	Sab Biotherapeutics / NCM:SABS	£3.95	£4.28	8.35%	£75,848.10

* Minimum Potential Value based on £70,000.00 invested at time of declaration.

** Interest ceased/exited on filed date.